Alogliptin Benzoate NEW

Allogliptin (US trade name: Nesina, European trade name: Vipidia) is an oral DPP-4 inhibitor anti diabetes drug. Alogliptin is the most selective marketed DPPIV inhibition and has similar PK and PD properties compared to previous entries. Like other members of the gliptin family, it almost does not lead to weight gain or no weight gain. The risk of hypoglycemia is relatively small, and it shows relatively mild hypoglycemic activity.

Aloglutinin and other gliptins are usually used in combination with metformin for patients with diabetes that cannot be adequately controlled by metformin alone.

Hebei Jingbo New Material Technology Co., Ltd. was founded in 2007 , located in Shijiazhuang city which is the capital of Hebei Province and hub sector among Beijing Tianjin and Hebei and has advantage of convenient transportation . Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.Our company has strong technical strength, advanced equipment, strict quality management system and high-quality after-sales service, adhers to the "customer first and forge ahead" business philosophy and insists on integrity as the company's survival.